5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.83▼ | 2.83▼ | 2.83▼ | 2.90▼ | 2.61▲ |
MA10 | 2.83▼ | 2.85▼ | 2.91▼ | 2.59▲ | 2.81▼ |
MA20 | 2.94▼ | 2.89▼ | 2.87▼ | 2.59▲ | 3.12▼ |
MA50 | 2.87▼ | 2.92▼ | 2.72▲ | 2.84▼ | 97.90▼ |
MA100 | 2.93▼ | 2.67▲ | 2.63▲ | 3.37▼ | 611.18▼ |
MA200 | 2.75▲ | 2.68▲ | 2.79▲ | 33.15▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.016▼ | -0.013▼ | -0.024▼ | 0.079▲ | 11.732▲ |
RSI | 39.975▼ | 44.662▼ | 48.649▼ | 52.079▲ | 24.985▼ |
STOCH | 26.323 | 12.965▼ | 17.647▼ | 63.755 | 26.985 |
WILL %R | -93.750▼ | -95.385▼ | -76.543▼ | -43.429 | -58.380 |
CCI | -68.462 | -61.880 | -36.769 | 96.450 | 0.139 |
Monday, December 02, 2024 05:43 AM
FORT LAUDERDALE, FL / ACCESSWIRE / December 2, 2024 / Sunshine Biopharma Inc. (NASDAQ:"SBFM") (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/12/24 | 3.17 | 3.17 | 2.79 | 2.79 | 214,122 |
02/12/24 | 2.93 | 3.15 | 2.72 | 3.10 | 527,459 |
29/11/24 | 2.77 | 2.91 | 2.71 | 2.86 | 143,377 |
27/11/24 | 3.18 | 3.3154 | 2.70 | 2.73 | 552,331 |
26/11/24 | 2.38 | 3.10 | 2.38 | 3.04 | 1,558,496 |
25/11/24 | 2.30 | 2.56 | 2.20 | 2.44 | 753,604 |
22/11/24 | 2.32 | 3.039 | 2.18 | 2.36 | 26,963,933 |
21/11/24 | 2.18 | 2.20 | 2.1056 | 2.12 | 49,926 |
20/11/24 | 2.29 | 2.336 | 2.18 | 2.18 | 52,779 |
19/11/24 | 2.29 | 2.32 | 2.20 | 2.28 | 64,589 |
|
|
||||
|
|
||||
|
|